Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression.
about
A trial of somatic gene targeting in vivo with an adenovirus vector.The adenovirus genome contributes to the structural stability of the virionComponents of Adenovirus Genome PackagingViral capsid is a pathogen-associated molecular pattern in adenovirus keratitisAdenoviral vector immunity: its implications and circumvention strategies.Current strategies and future directions for eluding adenoviral vector immunityTransductional targeting of adenovirus vectors for gene therapyTranscriptional Response of Human Neurospheres to Helper-Dependent CAV-2 Vectors Involves the Modulation of DNA Damage Response, Microtubule and Centromere Gene Groups.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advancesX-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector.Helper-dependent adenoviral vectors in experimental gene therapy.Identification of cellular proteins that interact with the adeno-associated virus rep proteinAdenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.Innate immunity to adenovirus.pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.Packaging of viral RNAs in virions of adenovirusesEndothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery.Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells.Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.Role of MyD88 in adenovirus keratitis.Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomasSustained viral gene delivery through core-shell fibers.Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair.
P2860
Q24813890-F8AFCB9B-C8C0-46CD-A875-94125E9FEE0BQ26825101-98A9257E-52A6-4135-BB69-CFC48E7642FCQ28072356-7DD2AAB3-87CC-4559-9522-D127FEEB0989Q33564368-AFA30656-80F4-449F-BF89-5D90A8070809Q33565630-C053F4C5-B667-4F23-A258-32998AB6C76EQ34585554-FC80DEB1-E509-408B-876E-4B766BB605B0Q35609035-4882C064-5BC2-4D21-87E3-C4D216FE6835Q35710695-8676BA9D-2394-4EDB-A31F-D033A0F0C3E2Q35847178-E2F7DE9C-2B2D-4B27-B8B4-7F8EFD26786FQ36084459-10176D67-3A4F-475B-BA59-FD70392149F1Q36219334-E181C265-7F25-4BEF-BBDC-F538E2B1B3F1Q37033220-F62EDF8F-5FC4-4594-9B39-11A9FFC6B009Q37157210-2D3C9691-1F44-49C9-A13B-FFF5BB691C79Q37718852-C90741E7-6519-44FD-A82D-CC05499FFAD4Q38461882-8FBBF32F-A7F6-4CF5-A69C-1215AC8FFD06Q39887000-2CA68FB9-0DB0-46BF-B028-D9B5EE83A37AQ40309219-4E77BC94-FB66-4D7C-82DA-B605A4FA44F0Q40396580-5D016A77-8837-45FA-95B5-AB6D3E5A2D99Q40514543-26FE6512-43FC-468A-A85B-DDAC5F3898A4Q40574656-508E53CB-7BD0-42A6-8F17-1388342FC46DQ42397243-4AE87CEC-0820-42B5-94FD-E8ACA1FF6AA1Q42561096-B533CB12-C9DE-45D0-B068-E96EC81FF42EQ42860274-C42F1B28-7570-4EE7-A87C-9B2C9DCB2824
P2860
Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Development and characterizati ...... t on cellular gene expression.
@en
type
label
Development and characterizati ...... t on cellular gene expression.
@en
prefLabel
Development and characterizati ...... t on cellular gene expression.
@en
P2093
P2860
P1433
P1476
Development and characterizati ...... t on cellular gene expression.
@en
P2093
Atsuko Negishi
Douglas M McCarty
Jackie L Stilwell
R Jude Samulski
Richard Superfine
P2860
P304
12881-12885
P356
10.1128/JVI.77.23.12881-12885.2003
P407
P577
2003-12-01T00:00:00Z